全球巴比妥類藥物市場 2024-2031

巴比妥類藥物市場預計在預測期內（2024-2031年）將以 3.5%的年複合成長率適度成長。巴比妥類藥物是一類從巴比妥酸化學衍生的鎮靜藥物。它們被用作鎮靜劑、催眠劑和抗驚厥劑。巴比妥類藥物透過減慢中樞神經系統的活動而產生睡意和放鬆。

市場動態

目錄

第1章 報告摘要

• 目前行業分析及成長潛力展望
• 研究方法和工具
• 市場區隔
  • 依細分
  • 依地區

第2章 市場概述與見解

• 報告範圍
• 分析師見解和當前市場趨勢
  • 主要發現
  • 建議
  • 結論

第3章 競爭格局

• 主要公司分析
• Abbott Laboratories
  • 概述
  • 財務分析
  • SWOT分析
  • 最近的發展
• Par Pharmaceutical
  • 概述
  • 財務分析
  • SWOT分析
  • 最近的發展
• Samarth Life Sciences Pvt. Ltd.
  • 概述
  • 財務分析
  • SWOT分析
  • 最近的發展
• 關鍵策略分析

第4章 市場細分

• 全球巴比妥類藥物市場（依類型）
  • 長效型巴比妥類藥物
  • 短效型巴比妥類藥物
  • 超短效巴比妥類藥物
  • 複方藥物
• 全球巴比妥類藥物市場（依應用）
  • 失眠
  • 癲癇
  • 鎮靜
  • 其他應用

第5章 區域分析

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 西班牙
  • 法國
  • 歐洲其他地區
• 亞太
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 世界其他地區

第6章 公司簡介

• AbbVie Inc.
• Centurion Healthcare Private Ltd.
• Ethypharm
• GSK Plc.
• Intas Pharmaceuticals Ltd.
• Johnson & Johnson
• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.

Global Barbiturate Drug Market Size, Share & Trends Analysis Report by Type (Long-acting Barbiturate, Short-acting Barbiturate, Ultra-short Acting Barbiturate and Combination Drugs), and by Application (Insomnia, Epilepsy, Sedation and Other Applications) Forecast Period (2024-2031)

Barbiturate drug market is anticipated to grow at a moderate CAGR of 3.5% during the forecast period (2024-2031). Barbiturates are a class of depressant drugs that are chemically derived from barbituric acid. They are used as sedatives, hypnotizers, and anticonvulsants. Barbiturates produce drowsiness and relaxation by slowing down the central nervous system's activity.

Market Dynamics

Growing geriatric population

The market for barbiturate medications is mostly driven by the increase in the geriatric population. Due to age-related changes and medical issues, sleep disturbances among older adults have increased as the world's population ages. The use of barbiturate medications to treat common sleep problems in the elderly is becoming increasingly popular. The demand for pharmacological remedies has increased as seniors become more conscious of the negative effects untreated sleep disturbances can have on their health.

Rising patient awareness and education for pharmaceutical products

The market for barbiturate medications is driven mostly by patient awareness and education, which enable knowledgeable people to actively participate in healthcare decisions. Campaigns and educational programs, among other things, demonstrate how well barbiturate medications work to treat neurological disorders including anxiety and epilepsy. There is a greater need for pharmaceutical interventions, particularly barbiturates, as a result of this better awareness. Through the promotion of educated dialogues between medical practitioners and patients, these initiatives impact not just the decisions made about individual treatments but also the larger healthcare landscape, reshaping prescription practices and market dynamics. Barbiturate drug acceptance and use are further influenced by the increased awareness of mental health disorders.

Market Segmentation

Our in-depth analysis of the global barbiturate drug market includes the following segments by type and application:

• Based on type, the market is sub-segmented into long-acting barbiturate, short-acting barbiturate, ultra-short-acting barbiturate and combination drugs.
• Based on application, the market is bifurcated into insomnia, epilepsy, sedation, and other applications.

Long-acting Barbiturate is Projected to Emerge as the Largest Segment

The long-acting category holds a major market share in 2023. To treat epilepsy, long-acting barbiturates have been employed, such as phenobarbital. Their prolonged management of seizures and comparatively low dosage requirements contribute to their prominence. Compared to their counterparts, long-acting barbiturates are being used more frequently to treat individuals who have a history of anxiety and seizures. The medicine is mostly used to sedate people during the day.

Epilepsy Sub-segment to Hold a Considerable Market Share

Medications classified as first-generation antiepileptics are barbiturate-based. These were some of the first drugs ever developed to treat epilepsy. Furthermore, phenobarbital has been used for many years to help epileptic people regulate their seizures. However, the negative impacts such as sedation, adverse effects, and dependence on barbiturates have decreased its usage in past years.

Regional Outlook

The global barbiturate drug market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

Asia-Pacific countries to invest more in the pharmaceutical industry

• Barbiturates are easily accessible through online pharmacies, facilitating rapid market expansion in the Asia-Pacific region. The increasing need for barbiturates in this region is driven by their effectiveness in treating a variety of ailments, including epilepsy, insomnia, and nonepileptic seizures.

North America Holds Major Market Share

The rise in anxiety, epilepsy, and insomnia cases along with rising healthcare costs are predicted to fuel the regional market expansion. About 20.0% of Americans suffer from sleeping difficulties annually, according to the American Academy of Sleep Medicine 2020. Additionally, the Centers for Disease Control and Prevention estimates that 3 million people and 470,000 children in the US have active epilepsy in 2020. The combined number of Americans with multiple sclerosis, Parkinson's disease, and cerebral palsy is less than that of those with epilepsy. As a result, the need for efficient medications like barbiturates is growing in the area, which is fueling the growth of the regional barbiturates market.

The major companies serving the global barbiturate drug market include Par Pharmaceutical, Sun Pharmaceutical Industries Ltd., Samarth Life Sciences Pvt. Ltd., Ethypharm, Abbott, and Centurion Healthcare Private Ltd., among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers, and acquisitions to stay competitive in the market.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. Abbott Laboratories
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. Par Pharmaceutical
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. Samarth Life Sciences Pvt. Ltd.
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Barbiturate Drug Market by Type
  • 4.1.1. Long-acting Barbiturate
  • 4.1.2. Short-acting Barbiturate
  • 4.1.3. Ultra-short Acting Barbiturate
  • 4.1.4. Combination Drugs
• 4.2. Global Barbiturate Drug Market by Application
  • 4.2.1. Insomnia
  • 4.2.2. Epilepsy
  • 4.2.3. Sedation
  • 4.2.4. Other Applications

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World

6. Company Profiles

• 6.1. AbbVie Inc.
• 6.2. Centurion Healthcare Private Ltd.
• 6.3. Ethypharm
• 6.4. GSK Plc.
• 6.5. Intas Pharmaceuticals Ltd.
• 6.6. Johnson & Johnson
• 6.7. Merck & Co. Inc.
• 6.8. Novartis AG
• 6.9. Pfizer Inc.
• 6.10. Sun Pharmaceutical Industries Ltd.
• 6.11. Teva Pharmaceutical Industries Ltd.

LIST OF TABLES

• 1. Global Barbiturate Drug Market Research And Analysis By Type, 2023-2031 ($ Million)
• 2. Global Long-Acting Barbiturate Drug Market Research And Analysis By Region, 2023-2031 ($ Million)
• 3. Global Short-Acting Barbiturate Drug Market Research And Analysis By Region, 2023-2031 ($ Million)
• 4. Global Ultra-Short Acting Barbiturate Drug Market Research And Analysis By Region, 2023-2031 ($ Million)
• 5. Global Combination Barbiturate Drug Market Research And Analysis By Region, 2023-2031 ($ Million)
• 6. Global Barbiturate Drug Market Research And Analysis By Application, 2023-2031 ($ Million)
• 7. Global Barbiturate Drug For Insomnia Market Research And Analysis By Region, 2023-2031 ($ Million)
• 8. Global Barbiturate Drug For Epilepsy Market Research And Analysis By Region, 2023-2031 ($ Million)
• 9. Global Barbiturate Drug For Sedation Market Research And Analysis By Region, 2023-2031 ($ Million)
• 10. Global Barbiturate Drug For Other Application Market Research And Analysis By Region, 2023-2031 ($ Million)
• 11. Global Barbiturate Drug Market Research And Analysis By Region, 2023-2031 ($ Million)
• 12. North American Barbiturate Drug Market Research And Analysis By Country, 2023-2031 ($ Million)
• 13. North American Barbiturate Drug Market Research And Analysis By Type, 2023-2031 ($ Million)
• 14. North American Barbiturate Drug Market Research And Analysis By Application, 2023-2031 ($ Million)
• 15. European Barbiturate Drug Market Research And Analysis By Country, 2023-2031 ($ Million)
• 16. European Barbiturate Drug Market Research And Analysis By Type, 2023-2031 ($ Million)
• 17. European Barbiturate Drug Market Research And Analysis By Application, 2023-2031 ($ Million)
• 18. Asia-Pacific Barbiturate Drug Market Research And Analysis By Country, 2023-2031 ($ Million)
• 19. Asia-Pacific Barbiturate Drug Market Research And Analysis By Type, 2023-2031 ($ Million)
• 20. Asia-Pacific Barbiturate Drug Market Research And Analysis By Application, 2023-2031 ($ Million)
• 21. Rest Of The World Barbiturate Drug Market Research And Analysis By Region, 2023-2031 ($ Million)
• 22. Rest Of The World Barbiturate Drug Market Research And Analysis By Type, 2023-2031 ($ Million)
• 23. Rest Of The World Barbiturate Drug Market Research And Analysis By Application, 2023-2031 ($ Million)

LIST OF FIGURES

• 1. Global Barbiturate Drug Market Share By Type, 2023 Vs 2031 (%)
• 2. Global Long-Acting Barbiturate Drug Market Share By Region, 2023 Vs 2031 (%)
• 3. Global Short-Acting Barbiturate Drug Market Share By Region, 2023 Vs 2031 (%)
• 4. Global Ultra-Short-Acting Barbiturate Drug Market Share By Region, 2023 Vs 2031 (%)
• 5. Global Combination Barbiturate Drug Market Share By Region, 2023 Vs 2031 (%)
• 6. Global Barbiturate Drug Market Share By Application, 2023 Vs 2031 (%)
• 7. Global Barbiturate Drug For Insomnia Market Share By Region, 2023 Vs 2031 (%)
• 8. Global Barbiturate Drug For Epilepsy Market Share By Region, 2023 Vs 2031 (%)
• 9. Global Barbiturate Drug For Sedation Market Share By Region, 2023 Vs 2031 (%)
• 10. Global Barbiturate Drug For Other Application Market Share By Region, 2023 Vs 2031 (%)
• 11. Global Barbiturate Drug Market Share By Region, 2023 Vs 2031 (%)
• 12. US Barbiturate Drug Market Size, 2023-2031 ($ Million)
• 13. Canada Barbiturate Drug Market Size, 2023-2031 ($ Million)
• 14. UK Barbiturate Drug Market Size, 2023-2031 ($ Million)
• 15. France Barbiturate Drug Market Size, 2023-2031 ($ Million)
• 16. Germany Barbiturate Drug Market Size, 2023-2031 ($ Million)
• 17. Italy Barbiturate Drug Market Size, 2023-2031 ($ Million)
• 18. Spain Barbiturate Drug Market Size, 2023-2031 ($ Million)
• 19. Rest Of Europe Barbiturate Drug Market Size, 2023-2031 ($ Million)
• 20. India Barbiturate Drug Market Size, 2023-2031 ($ Million)
• 21. China Barbiturate Drug Market Size, 2023-2031 ($ Million)
• 22. Japan Barbiturate Drug Market Size, 2023-2031 ($ Million)
• 23. South Korea Barbiturate Drug Market Size, 2023-2031 ($ Million)
• 24. Rest Of Asia-Pacific Barbiturate Drug Market Size, 2023-2031 ($ Million)
• 25. Latin America Barbiturate Drug Market Size, 2023-2031 ($ Million)
• 26. Middle East And Africa Barbiturate Drug Market Size, 2023-2031 ($ Million)